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NK cells are a subset of lymphoid cells that play 
a fundamental role in defense against intracel-
lular pathogens, tumor surveillance, and the 
production of cytokines that promote adaptive 
immune responses (1). Over the past 5 yr, major 
advances have been made in our understanding 
of how NK cells recognize and kill their targets 
(2–4). In contrast, much less is known about 
how these cells develop from progenitors in the 
BM, the major site of NK cell production. NK 
cells are the progeny of common lymphoid pro-
genitors (CLPs) that also give rise to B lympho-
cytes in the BM and lymphoid tissue–inducing 
(LTi) cells in the fetal liver (5–8). During em-
bryogenesis, NK cells develop in the thymus 
from a bipotent T/NK cell progenitor, and an 
analogous progenitor likely exists in the adult 
thymus (9–14). In the BM, the most immature 
lineage-restricted NK cell progenitors (NKPs) 
can be identifi  ed by the expression of the β 
chain of the IL-2/15 receptor (CD122) and the 
absence of cell surface markers associated with T 
lymphocytes, such as TCRαβ, TCRγδ, CD3, 
CD4, and CD8 (15, 16). As NK cells mature, 
they sequentially acquire the cell surface recep-
tors NK1.1 (NKR-P1B and NKR-P1C), CD94, 
and the α2-integrin DX5 (CD49b; references 
15, 16). CD122+NK1.1−DX5− NKPs and 
CD122+NK1.1+DX5− immature (i) NK cells 
lack lytic capacity, whereas CD122+NK1.1+
DX5+ mature (m) NK cells can lyse cells after 
their specifi  city is fi  ne-tuned by stochastic ex-
pression of activating and inhibitory receptors 
of the Ly49 family (15, 17). In the adult thymus, 
a subpopulation of NK cells develop through a 
unique GATA-3 and IL-7– dependent pathway, 
resulting in NK cells with enhanced ability to 
secrete TNFα and IFNγ (14). However, little 
is known about the requirements for develop-
ment of these “thymic” NK cells.
Development of mNK cells in the BM, and 
their subsequent accumulation in the spleen, 
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The Id2 transcriptional repressor is essential for development of natural killer (NK) cells, 
lymphoid tissue–inducing (LTi) cells, and secondary lymphoid tissues. Id2 was proposed to 
regulate NK and LTi lineage specifi  cation from multipotent progenitors through suppression 
of E proteins. We report that NK cell progenitors are not reduced in the bone marrow (BM) 
of Id2−/− mice, demonstrating that Id2 is not essential for NK lineage specifi  cation. Rather, 
Id2 is required for development of mature (m) NK cells. We defi  ne the mechanism by which 
Id2 functions by showing that a reduction in E protein activity, through deletion of E2A, 
overcomes the need for Id2 in development of BM mNK cells, LTi cells, and secondary 
lymphoid tissues. However, mNK cells are not restored in the blood or spleen of Id2−/−E2A−/− 
mice, suggesting a role for Id2 in suppression of alternative E proteins after maturation. 
Interestingly, the few splenic mNK cells in Id2−/− and Id2−/−E2A−/− mice have characteristics 
of thymus-derived NK cells, which develop in the absence of Id2, implying a differential 
requirement for Id2 in BM and thymic mNK development. Our fi  ndings redefi  ne the essential 
functions of Id2 in lymphoid development and provide insight into the dynamic regulation 
of E and Id proteins during this process.
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requires expression of CD122, the common γ chain (γc) for 
cytokine receptors, IL-15Rα, and IL-15, all of which are 
necessary for IL-15–mediated expansion of iNK and mNK 
cells (18–20). However, IL-15 and other γc-dependent cyto-
kines are not required for development of NKPs (18, 21–24). 
Several Ets family transcription factors, including Ets1, MEF-1, 
and PU.1, have been implicated in development of mNK 
cells, but the precise stage at which these factors are required 
has not been well defi  ned (25–27). In addition, the helix-
loop-helix protein Id2 is required for development of mNK 
cells in the spleen and all CD122+ NK lineage cells in the 
  fetal thymus, leading to the hypothesis that Id2 may be 
  required for emergence of the fi  rst committed NKPs from 
CLPs or an analogous fetal thymic progenitor (28, 29). Inter-
estingly, Id2 is also required for the development of LNs, 
Peyer’s patches (PP), and nasal-associated lymphoid tissues, as 
well as the LTi cells that are required for formation of these 
secondary lymphoid organs (28, 30, 31). Because NK and 
LTi cells both develop from CLPs in the fetal liver, it was 
suggested that Id2 may regulate development of a common 
NK/LTi progenitor from CLPs or directly regulate cell-fate 
specifi  cation from CLPs (32, 33).
Id2 is an antagonist of E protein transcription factor activ-
ity and functions by binding to E proteins and preventing 
their association with E box sequences in DNA (34). The E 
proteins encoded by the E2A gene, E12 and E47, are essen-
tial for development of committed B lymphocyte progenitors 
from CLPs as a result of their role in the induction of the 
B lineage transcription factor early B cell factor (EBF) and 
subsequent activation of Pax-5, which commits cells to the 
B lymphocyte lineage (35–38). Therefore, an attractive hy-
pothesis for the role of Id2 in NK and LTi cell development 
is that Id2 functions to inhibit E protein activity in a subset of 
CLPs, allowing these cells to adopt non–B lineage cell fates 
by preventing activation of EBF and Pax-5 and consequent B 
lymphocyte lineage commitment (13, 33). However, Id2 has 
been proposed to have targets in addition to E proteins that 
could function in NK and LTi cell development, including 
the Ets family proteins PU.1 and the retinoblastoma protein 
(39–41). Therefore, a role for excess E protein activity in the 
lymphoid phenotype of Id2−/− mice remains to be demon-
strated. Moreover, a requirement for Id2 in the B lympho-
cyte versus NK cell fate decision in adult BM has not been 
directly established.
Here, we demonstrate that Id2 is not required for devel-
opment of committed NKPs but is required specifi  cally for 
development of mNK cells in adult BM. We fi  nd that all of 
the E proteins, E2A, HEB, and E2-2, as well as Id2, are ex-
pressed at varying levels throughout NK cell development. 
In contrast, Id3 is highly expressed in NKPs, but it is down-
  regulated in mNK cells, leaving Id2 as the major Id regulator 
of E protein activity in these cells. Importantly, we show that 
lowering E protein activity in Id2−/− mice by deletion of 
E2A results in the restoration of mNK cells in the BM and 
LTi cells in the embryo, as well as LNs and PPs. Therefore, 
excess E protein activity is the major cause of the lymphoid 
phenotypes in Id2−/− mice. Surprisingly, we fi  nd that mNK 
cells in Id2−/−E2A−/− mice fail to accumulate in the periph-
eral blood or spleen, suggesting that these cells fail to emi-
grate from the BM. Moreover, the few mNK cells present in 
the spleen of both Id2−/− and Id2−/−E2A−/− mice express 
IL-7Rα and low levels of CD11b and CD43, which are 
characteristic of thymic mNK cells. Because thymic NK cell 
development is not perturbed in Id2−/− mice, this observa-
tion suggests a thymic rather than BM origin for mNK cells 
Figure 1.  Decreased production of mNK cells, but not NKP, in BM 
of Id2−/− mice. (A) BM cells from Id2+/+ and Id2−/− mice were depleted 
of Lin+ cells and stained for CD122, NK1.1, and DX5. NK1.1 versus DX5 
(bottom) expression on Lin−CD122+ cells (top) is shown. (B) Total number 
of mNK (NK1.1+DX5+) and NK1.1hiDX5hi cells in BM of Id2+/+ (n = 9) and 
Id2−/− (n = 12) mice (P < 0.002 for both). Each circle represents the num-
ber of cells in femoral BM from one mouse. Bars represent the mean number 
of NK cells. (C) Total number of NKP and iNK in Id2+/+ and Id2−/− BM 
(NKP, P = 0.4; iNK, P = 0.08). (D) NKG2D expression on Lin−CD122+
NK1.1−DX5− BM NKPs from Id2+/+ (gray line) and Id2−/− (black line) mice. 
A negative Ig control (dashed line) is shown for comparison. (E) Thymocytes 
from Id2+/+ and Id2−/− mice were stained for Lin+ cells, CD122, DX5, and 
IL7Rα. DX5 versus IL7Rα on Lin−CD122+ cells is shown, with the gated 
population representing “thymic” mNK cells. Positive expression of DX5 and 
IL7Rα was determined in comparison with samples stained with isotype 
control antibody. (F) Total number of DX5+ mNK in the thymus of Id2+/+ 
(n = 9) and Id2−/− (n = 9) mice (P = 0.7). Each circle represents the num-
ber of cells in one mouse. Bars represent the mean number of NK cells. Mice 
used in A–C were mixed FVB/NJ × 129/SvJ, and mice used for D and E were 
backcrossed onto 129/SvJ more than eight times.JEM VOL. 204, May 14, 2007  1121
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in the spleen of these mice. Our data show for the fi  rst time 
that E proteins are the major target of Id2 in vivo and that E 
protein activity must be suppressed at multiple stages of BM 
NK cell development. These results provide important in-
sight into the mechanisms controlling NK and LTi cell dif-
ferentiation and dramatically alter our view of the requirements 
for Id2 and E proteins in these processes.
RESULTS
Id2 is essential for the development of mNK cells but not 
NKPs or iNK cells
Mice lacking the Id2 gene have a reduced number of mNK 
cells in the spleen; however, the requirement for Id2 in BM 
NK cell development has not been investigated thoroughly. 
To address this issue, we quantifi  ed the number of NKPs, 
iNK, and mNK cells in the BM of Id2+/+ and Id2−/− mice 
between 4 and 6 wk of age by fl  ow cytometry. All of our 
analyses included a cocktail of lineage-specifi  c antibodies to 
exclude T lymphocytes and other cell types (see Materials 
and methods). Consistent with previous reports, there is a 
10-fold decrease in the number of CD122+NK1.1+DX5+ 
mNK cells in Id2−/− BM when compared with Id2+/+ BM (Fig. 
1, A and B). The NK1.1hiDX5hi population is most severely 
aff  ected with a >40-fold decrease in Id2−/− compared with 
Id2+/+ BM. Surprisingly however, CD122+NK1.1−DX5− 
NKPs and CD122+NK1.1+DX5− iNK cells are present in 
similar numbers in Id2−/− and Id2+/+ BM (Fig. 1, A and 
C). The NK cell receptor NKG2D is expressed on a similar 
proportion of CD122+DX5− cells in Id2+/+ and Id2−/− BM, 
further confi  rming assignment of these cells to the NK lineage 
(Fig. 1 D). In addition, CD122+DX5− BM cells from Id2−/− 
and Id2+/+ cultured in vitro in c-kit ligand, Flt3 ligand, and 
IL-2, under limiting dilution conditions, had an identical fre-
quency of cells that were able to proliferate and diff  erentiate 
into CD122+CD94+ NK lineage cells (1:9; see Materials and 
methods). We note that we have examined mice on a mixed 
FVB/NJ × 129/SvJ background, where the anti-NK1.1 an-
tibody recognizes NKR-P1B, as well as mice backcrossed 
onto the 129/SvJ background, where the NK1.1 antigen is 
not expressed. In both sets of mice, we observe a similar de-
crease in mNK cells (Lin−CD122+DX5+) and no decrease in 
NKP/iNK cells (Lin−CD122+DX5−). Therefore, Id2 is not 
required for the development of NKPs in the adult BM but is 
required specifi  cally for development of mNK cells.
A subset of NK cells develops in the thymus, where these 
cells can be distinguished from BM NK cells by expression of 
IL7Rα (14). Surprisingly, we found that similar numbers of 
CD122+DX5+ mNK cells are present in the thymus of Id2+/+ 
and Id2−/− mice and these cells are predominantly IL7Rα+ 
(Fig. 1, E and F). Therefore, Id2 appears to be dispensable for 
development of mNK cells in the thymus.
Id2−/− splenic NK cells express NK cell receptors and IL7R𝗂 
and produce IFN𝗄
In contrast to the near complete absence of CD122+NK1.1hi
DX5hi mNK cells in Id2−/− BM, these cells can be detected 
in the spleen, albeit in reduced numbers compared with 
Id2+/+ mice (Fig. 2, A and B; reference 28). Further char-
acterization of Id2−/− splenic mNK cells revealed that they 
express the Ly49 receptors recognized by the Ly49 anti  bodies 
4E5, 4D11, and 5E6 at frequencies similar to those found 
in Id2+/+ mice, and a cocktail of these antibodies detects 
essentially all mNK cells in Id2−/− mice (Fig. 2 C and not 
depicted). A lower frequency of Id2−/− mNK cells express 
NKG2A/C/E than in Id2+/+ spleen, although the level of 
expression is slightly higher (Fig. 2 C). In contrast, although 
Figure 2.  Splenic mNK cells in Id2−/− mice are reduced in number 
and resemble thymic mNK cells. (A) Splenocytes were stained for 
Lin+ cells, CD122, NK1.1, and DX5. NK1.1 versus DX5 (bottom) on 
Lin−CD122+ cells (top) is shown. (B) Total number of Lin−CD122+DX5+ 
mNK cells in spleen of Id2+/+ (n = 10) and Id2−/− mice (n = 7; P < 
0.002). Each circle represents the number of cells in one spleen. Bars 
represent the mean number of NK cells. Ly49 receptor (detected with a 
mix of anti-Ly49 antibodies) and NKG2A/C/E (C) or CD43 and CD11b (D) 
expression on Lin−CD122+DX5+ cells from Id2+/+ (gray line) and Id2−/− 
(black line) splenocytes. Isotype control antibody (dashed line) is shown. 
Between three and eight mice were analyzed for each marker. (E) IL7Rα 
and DX5 expression on Lin−CD122+ splenocytes from Id2+/+ and Id2−/− 
mice. The boxed area represents IL7Rα+DX5+ cells based on isotype 
control staining of the same population and is representative of six in-
dependent experiments. (F) Lineage-depleted splenocytes from Id2+/+ 
and Id2−/− mice were cultured for 12 h with IL-2 and IL-12. Intracellular 
IFNγ expression in CD3−DX5+ cells is shown. Mice used in A and B were 
mixed FVB/NJ × 129/SvJ, and mice used in C–F were backcrossed more 
than eight times.1122  LOSS OF E2A RESCUES LYMPHOID DEFECTS IN ID2−/− MICE | Boos et al.
the majority of Id2−/− splenic mNK cells express CD43 and 
CD11b, these proteins are expressed at lower levels than 
on Id2+/+ cells (Fig. 2 D). Interestingly, we also found that 
the majority of Id2−/− splenic mNK cells express IL7Rα, a 
marker of thymus-derived NK cells, raising the possibility 
that these mNK cells are derived from Id2-independent thy-
mic NK cells rather than from Id2-dependent BM mNK cells 
(Fig. 2 E). Thymic NK cells also express low levels of CD43 
and CD11b, consistent with the phenotype of Id2−/− splenic 
mNK cells (14). Moreover, we did not observe any diff  er-
ences in in vitro survival or in vivo proliferation between 
Id2−/− and Id2+/+ splenic mNK cells, which is consistent 
with the hypothesis that the Id2−/− splenic mNK cells do 
not derive from expansion or survival of a small number of 
BM-derived mNK cells (unpublished data).
We next tested the ability of Id2−/− splenic mNK cells to 
produce IFNγ in vitro after overnight culture with IL-2 and 
IL-12. In WT mice, mNK cells from the thymus produce 
higher levels of IFNγ under these conditions than splenic 
mNK cells (14). In contrast, although a small fraction of 
Id2−/− mNK cells produce IFNγ, they produce less IFNγ on 
a per-cell basis than Id2+/+ mNK cells (Fig. 2 F). This fi  nding 
is consistent with a previous study showing that Id2−/− sple-
nocytes are able to lyse NK cell targets, although with re-
duced effi     ciency compared with Id2+/+ splenocytes (28). 
Collectively, these data indicate that the few mNK cells pres-
ent in Id2−/− spleen resemble thymic NK cells in that they 
express IL7Rα and low levels of CD43 and CD11b, but they 
produce lower levels of IFNγ than WT splenic mNK cells.
Expression of Id and E proteins during NK cell development
To determine why Id2 is required for development of mNK 
cells rather than at earlier stages of NK cell development, 
we examined Id and E protein mRNA expression in BM 
CLP, NKP, and mNK cells by quantitative real-time PCR 
(QPCR). All of the E proteins are expressed in each of these 
populations, with the mean ∆CT values for E47, E2-2, and 
HEB relative to HPRT (∆CTGENE-∆CTHPRT) in NKPs 
being 5.1, 3, and 2.35, respectively (unpublished data). E47 
mRNA levels are similar in CLPs and NKPs, whereas E2-2 
and HEB mRNA decrease during this developmental transi-
tion (Fig. 3 A). Additionally, diff  erentiation to the mNK cell 
stage is associated with a slight decline in E47 and E2-2 
mRNA (Fig. 3 A). Therefore, variable levels of mRNA for 
all of the E proteins are expressed in CLPs and throughout 
NK cell diff  erentiation, with the lowest levels being observed 
in mNK cells. By comparison, mRNA for the transcription 
factor Ets1, which is essential for development of mNK cells, 
is higher in NKPs and mNK cells compared with CLPs and 
pro-B lymphocytes (Fig. 3 B).
In contrast to the E proteins, Id2 is expressed at very 
low levels in CLPs but increases >15-fold in NKPs (mean 
∆CT = −2.5) and mNK cells (Fig. 3 B). Interestingly, Id3 
is expressed in CLPs and increases approximately twofold 
in NKPs but is reduced by 30-fold in mNK cells (Fig. 3 B). 
Id1 is expressed at lower levels in all NK cell populations 
and does not change substantially with diff  erentiation stage 
(∆CT = 4.39 in NKPs; unpublished data). Therefore, mRNA 
encoding all E proteins and Id1-3 are expressed in NK cells 
Figure 3.  E protein and Id gene expression in NK cell subsets. 
QPCR analysis of E47, E2-2, and HEB (A) and Id2, Id3, and Ets1 (B) in 
CLPs, pro-B lymphocytes (proB), and NKP, and mNK cells isolated from 
BM of C57Bl/6 mice. Similar results were observed using NKP and mNK 
from FVB/NJ × 129/SvJ mice. QPCR analysis of E47, E2-2, and HEB (C) 
and Id2, Id3, and Ets1 (D) in Id2+/+ and Id2−/− BM NKPs (mixed FVB/NJ × 
129/SvJ). E47, HEB, E2-2, and Ets1 ∆CT values are normalized to the 
level of expression in 38B9 pro-B lymphocytes (set to 1). Id2 ∆CT values 
are normalized to PTL, and Id3 ∆CT values are normalized to 70Z/3 
m/2C1 cells. All samples were run in triplicate, and the standard error 
is indicated. Experiment is representative of at least three indepen-
dent amplifi  cations.JEM VOL. 204, May 14, 2007  1123
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during development but show dynamic regulation between 
NKP and mNK cells. Moreover, we observed a dramatic 
decline in Id3 expression in mNK cells, the stage where 
Id2 becomes essential for further NK cell diff  erentiation. 
This fi   nding suggests that NKPs may develop in Id2−/− 
mice because Id3 is suffi   cient to compensate for loss of Id2. 
Consistent with this hypothesis, Id2−/− NKPs show an ap-
proximately twofold increase in Id3 mRNA compared with 
Id2+/+ NKPs (Fig. 3 D). Interestingly, E2-2 mRNA was 
observed to decrease, whereas E47 and HEB mRNA levels 
remain equivalent, in Id2−/− compared with Id2+/+ NKPs 
(Fig. 3 C). Therefore, alterations in E protein and Id3 ex-
pression may allow for NKP development in the absence 
of Id2.
Loss of E2A rescues mNK cell development in Id2−/− BM
Our data indicate that Id2 is essential for development of 
mNK cells in the BM, a stage where Id3 mRNA decreases 
dramatically. This observation suggests that in the absence of 
Id2, excess E protein activity may prevent further NK cell 
diff  erentiation. However, Id2 could also function by regulat-
ing non–E protein target genes. Therefore, to test the eff  ect 
of reducing E protein activity on the NK cell phenotype of 
Id2−/− mice, we created Id2−/− mice with varying levels of 
E2A and analyzed NK cell development in the BM by fl  ow 
cytometry. Remarkably, we found that loss of E2A in Id2−/− 
mice restores the number of CD122+DX5+ mNK cells in 
the BM to levels similar to Id2+/+ mice (Fig. 4, A and B). 
In addition, a partial rescue of mNK cell numbers is observed 
Figure 4.  Mature NK cell development is restored in the BM 
of Id2−/−E2A−/− mice. (A) Lin− BM cells from mice of the indicated geno-
type were analyzed for the presence of CD122+DX5+ mNK cells via fl  ow 
cytometry. (B) Total number of BM mNK cells for mice of the indicated 
genotype. Each circle represents the number of femoral mNK cells in one 
mouse, and bars represent the mean number of mNK cells. Id2+/+E2A+/+, 
n = 13; Id2+/+E2A−/−, n = 7; Id2−/−E2A+/+, n = 6; Id2−/−E2A+/−, n = 
10; Id2−/−E2A−/−, n = 7. Id2+/+E2A+/+ versus Id2−/−E2A−/−, P = 0.05; 
Id2−/−E2A+/+ versus Id2−/−E2A−/−, P < 0.05. Ly49 receptor, CD94, and 
NKG2A/C/E (C) or CD43 and CD11b (D) expression on Lin−CD122+DX5+ 
BM cells from Id2−/−E2A−/− (black line) and littermate control (Id2+/+
E2A+/− or Id2+/−E2A+/−; gray line) mice. Data is representative of two 
to six mice analyzed. (E) Lineage-depleted BM cells from Id2−/−E2A−/− 
and Id2+/+E2A+/− mice were cultured for 12 h with IL-2 and IL-12. Intra-
cellular IFNγ expression in CD3−DX5+ cells is shown. All mice were mixed 
FVB/NJ × 129/SvJ.
Table I.  LN development in Id2 and E2A mutant mice
Genotype
LNs
Mesenteric Cervical Axillary Brachial Inguinal
Id2+/+E2A+/+ 30/30 5/5 5/5 5/5 30/30
Id2+/+E2A−/− 11/11 ND ND ND 11/11
Id2−/−E2A+/+ 0/30 0/2 0/2 0/2 0/30
Id2−/−E2A+/− 24/24 5/5 3/5 1/5 6/24
Id2−/−E2A−/− 16/16 5/5 5/5 5/5 16/161124  LOSS OF E2A RESCUES LYMPHOID DEFECTS IN ID2−/− MICE | Boos et al.
in Id2−/−E2A+/− mice, indicating a dose eff   ect for E2A 
(Fig. 4 B). Importantly, mNK cell numbers are identical in 
Id2+/+ and E2A−/− mice, indicating that loss of E2A does 
not augment NK cell development when Id2 is present (Fig. 
4, A and B). Therefore, a reduction in E protein activity, 
through loss of E2A, is suffi   cient to restore mNK cells in 
Id2−/− BM.
The mNK cells that develop in Id2−/−E2A−/− BM ex-
press Ly49 receptors on a comparable frequency of cells 
as their Id2/E2A heterozygous (het) littermates, whereas 
slightly fewer cells express CD94 and NKG2A/C/E (Fig. 
4 C). Moreover, CD43 expression is indistinguishable be-
tween BM CD122+DX5+ mNK cells in Id2−/−E2A−/− and 
het mice, indicating that these cells are fully mature (Fig. 
4 D). In contrast, Id2−/−E2A−/− mNK cells do not express 
CD11b (Fig. 4 D). Decreased expression of CD11b did not 
inhibit functional activity, as Id2−/−E2A−/− mNKs were 
able to produce IFNγ in response to IL-2 and IL-12 stimu-
lation in vitro nearly as well as het littermates (Fig. 4 E). 
Therefore, loss of E2A in Id2−/− mice rescues the develop-
ment of BM mNK cells, although these cells lack expression 
of CD11b.
Loss of E2A fails to restore mNK cells in the spleen 
of Id2−/− mice
Given that loss of E2A rescues mNK cell development in the 
BM of Id2−/− mice, we next examined Id2−/−E2A−/− mice 
for the presence of mNK cells in the spleen. Remarkably, the 
total number of splenic mNK cells was not diff  erent between 
Id2−/−E2A+/+ and Id2−/−E2A−/− or Id2−/−E2A+/− animals 
(Fig. 5, A and B). This surprising result indicates that loss of 
E2A does not lower E protein activity suffi   ciently to allow 
mNK cells to accumulate in the spleen. Indeed, the few 
mNK cells present in Id2−/−E2A−/− spleen, like Id2−/− 
splenic mNK cells, expressed IL7Rα and low levels of CD43 
and CD11b, suggesting that they may also be derived from 
thymic NK cells (Fig. 5 C and not depicted). Interestingly 
however, IFNγ production by Id2−/−E2A−/− splenic mNK 
cells was closer to that of control (het) mNK cells than previ-
ously observed for Id2−/− splenic mNK cells (Fig. 5 D). 
Therefore, although loss of E2A may not rescue the number 
of mNK cells in the spleen, these cells respond better to IL-2 
and IL-12 than Id2−/− cells with WT levels of E2A.
To determine why BM-derived mNK cells were not 
present in the spleen of Id2−/−E2A−/− mice, we investigated 
Figure 5.  Loss of E2A does not rescue the phenotype of mNK cells 
in Id2−/− spleen. (A) FACS analysis for CD122 and DX5 on Lin− spleno-
cytes from mice with the indicated genotype. (B) Total number of Lin− 
mNK cells in the spleen of mice with the indicated genotype. Each circle 
represents the number of mNK cells in one spleen, and bars represent the 
mean number of mNK cells. Id2+/+E2A+/+, n = 13; Id2+/+E2A−/−, n = 7; 
Id2−/−E2A+/+, n = 6; Id2−/−E2A+/−, n = 10; Id2−/−E2A−/−, n = 7. 
(C) DX5 and IL7Rα expression on Lin−CD122+ splenocytes from Id2+/+
E2A+/− and Id2−/−E2A−/− mice. Data is representative of at least three 
mice of each genotype. (D) Lin-depleted splenocytes from Id2−/−E2A−/− 
and Id2+/+E2A+/− mice were cultured for 12 h with IL-2 and IL-12. Intra-
cellular IFNγ expression in CD3−DX5+ cells is shown. (E) CD122 and DX5 
expression on Lin− peripheral blood from Id2−/−E2A−/− and Id2+/−E2A+/− 
mice. Data is representative of four separate experiments. All mice were 
mixed FVB/NJ × 129/SvJ.JEM VOL. 204, May 14, 2007  1125
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whether these cells were accumulating in peripheral blood. 
Remarkably, the percentage of mNK cells among Lin− blood 
cells was reduced by 10-fold in Id2−/−E2A−/− mice com-
pared with het littermates (Fig. 5 E). Therefore, we reasoned 
that BM mNK cells in Id2−/−E2A−/− mice may fail to 
  emigrate from the BM into the peripheral blood. Regardless, 
we found no diff   erences in mRNA expression for the 
chemokine receptors CCR1, CCR5, or CX3CR1 by QPCR 
in mNK cells isolated from Id2−/−E2A−/− or het BM, indi-
cating that dysregulation of these chemokine receptors is 
  unlikely to be the cause of failed BM emigration (unpub-
lished data).
Loss of E2A rescues LN, PP, and LTi cell development 
in the absence of Id2
LNs and PPs do not develop in Id2−/− mice because of a 
failure of LTi cell development during embryogenesis (28). 
Given that loss of E2A rescues mNK cell development in 
Id2−/− mice, we examined these animals for the presence of 
LNs and PPs. Inguinal and mesenteric LNs were readily visi-
ble in Id2−/−E2A−/− mice, whereas no LNs were detected in 
Id2−/− mice, even after in vivo staining with Chicago sky 
blue (Table I and Fig. 6 A). Further inspection revealed that 
axillary, brachial, and cervical LNs, as well as PPs, develop in 
Id2−/−E2A−/− but not Id2−/− mice (Table I and Fig. 6 B). 
The LNs and PPs developing in Id2−/−E2A−/− mice are 
smaller that those in WT mice because of the absence of 
  mature B lymphocytes in these animals (unpublished data). 
Interestingly, mesenteric and cervical LNs were always present 
in Id2−/−E2A+/− mice, but axillary, brachial, and inguinal 
LNs developed in only a fraction of these mice, again indicat-
ing a dose eff  ect for E protein activity (Table I). B and T 
lymphocytes areas were observed in Id2−/−E2A+/− LNs that 
were indistinguishable from those in E2A+/− LNs, whereas 
only T lymphocytes were detected in LNs from Id2−/−
E2A−/− and E2A−/− mice as expected (unpublished data). 
Therefore, a decrease in E protein activity through loss of 
E2A is suffi   cient to overcome the need for Id2 in secondary 
lymphoid tissue organogenesis.
The presence of LNs and PPs in Id2−/−E2A−/− mice 
indicates that LTi cells are able to develop during embry-
onic life. To determine directly whether LTi cells develop 
in Id2−/−E2A−/− mice, embryonic day 15.5 embryos from 
breedings of Id2+/−E2A+/− mice were sectioned and stained 
with antibodies that detect CD4 or CD45, expressed on LTi 
cells, and intercellular adhesion molecule (ICAM) 1 or vas-
cular cell adhesion molecule (VCAM) 1, which are induced 
on stromal “organizer” cells through interaction with LTi 
cells (42). A distinct population of CD4+ cells could be found 
in association with VCAM-1+ cells in the cervical region 
of E2A−/− and Id2−/−E2A−/− embryos but not in Id2−/− 
embryos (Fig. 6 C). Similarly, CD45+ LTi cells are found in 
association with ICAM-1+ cells in the omentum of E2A−/− 
and Id2−/−E2A−/− embryos but not Id2−/− embryos (Fig. 6 D). 
Figure 6.  Development of LNs, PPs, and LTi cells in Id2−/−E2A−/− 
mice. (A) Inguinal LNs from Id2+/−E2A+/+, Id2−/−E2A+/+, Id2−/−E2A+/−, 
and Id2−/−E2A−/− mice were examined 2 wk after injection of Chicago 
sky blue. Bar, 0.5 cm. (B) Intestinal PPs were examined in Id2+/+E2A+/+, 
Id2−/−E2A+/+, Id2−/−E2A+/−, and Id2−/−E2A−/− mice after treatment with 
acetic acid. Bar, 0.5 cm. (C and D) Cryosections of fi  xed embryonic day 
15.5 embryos were stained with antibodies detecting LTi cells or stromal 
“organizer” cells. (C) CD4 (red) and VCAM-1 (green) in the cervical region 
of the embryo and CD45 (D, green) and ICAM-1 (red) in the omentum. All 
mice were mixed FVB/NJ × 129/SvJ. Bars, 100 μm.1126  LOSS OF E2A RESCUES LYMPHOID DEFECTS IN ID2−/− MICE | Boos et al.
Therefore, loss of E2A is suffi   cient to restore LTi cells and 
peripheral lymphoid tissues, in addition to BM mNK cells, 
in Id2−/− mice.
D  I  S  C  U  S  S  I  O  N 
In this study, we have shown that Id2 is required for the de-
velopment of mNK cells in adult BM, as well as formation of 
LTi cells, and that it functions by repressing E protein activ-
ity. The requirement for Id2 in BM NK cell development 
coincides with the down-regulation of Id3, suggesting that 
Id2 becomes the major antagonist of E proteins in mNK cells, 
whereas Id3 and Id2 may function redundantly in more im-
mature progenitors. All of the E protein genes are expressed 
during NK cell development, but loss of E2A, through ho-
mologous recombination, reduced total E protein activity 
suffi   ciently to allow mNK cell development in the absence of 
Id2. Remarkably, however, a further reduction in E protein 
activity may be required for accumulation of normal num-
bers of BM-derived mNK cells in the spleen and peripheral 
blood. Loss of E2A was also found to be suffi   cient to restore 
LTi cells and the peripheral lymphoid tissues that arise from 
LTi cell activity in Id2−/− mice. Although Id2 has been sug-
gested to interact with non–E protein targets, such as retino-
blastoma protein and PU.1 (40, 43), our data indicate that the 
essential function of Id2 in lymphoid development is modu-
lation of E protein activity. Moreover, our data provide the 
fi  rst genetic evidence for an interaction between an E and Id 
protein in vivo.
Previous studies have led to the hypothesis that Id pro-
teins function in the B/NK or T/NK lineage decision by 
inhibiting E protein activity and preventing B or T lympho-
poiesis, thereby allowing NK cell development (29, 33, 44). 
Consistent with this hypothesis, we show that Id2 is dramati-
cally up-regulated during the transition of CLPs to NKPs and 
remains highly expressed throughout NK cell development. 
However, we also found that Id2 is not essential for devel-
opment of NKPs in adult BM. This unexpected fi  nding is 
likely the result of compensation by Id3, as we found that Id3 
mRNA is expressed in CLPs and NKPs and is increased in 
Id2−/− NKPs. Therefore, in the absence of Id2, NKPs may 
be able to suppress E protein activity suffi   ciently via Id3 to 
allow their development. However, the role of Id proteins in 
supporting NK lineage specifi  cation from CLPs in adult BM 
requires further investigation.
We also fi  nd that Id2 is not essential for development of 
CD122+DX5+ mNK cells in the thymus and that the ma-
jority of Id2−/− and Id2−/−E2A−/− splenic mNK cells have 
characteristics of thymus-derived NK cells, including expres-
sion of IL7Rα and low levels of CD43 and CD11b (14). Al-
though this observation suggests that the mNK cells present 
in the spleen of Id2−/− and Id2−/−E2A−/− mice are derived 
from the thymic NK cell pathway, we cannot fully exclude 
the possibility that loss of Id2 causes BM-derived mNK cells 
to acquire the thymic phenotype. A previous study by Ikawa 
et al. (29) showed that CD44+CD25−CD122+ NKPs were 
absent in Id2−/− fetal thymus. Therefore, the requirements 
for Id2 in adult and fetal NK cell development may diff  er. 
Fetal and adult lymphopoiesis diff  er in many ways, including 
distinct relationships between progenitor cells and diff  erent 
cytokine and transcription factor requirements. For example, 
fetal liver CLPs can give rise to macrophages and LTi cells 
in addition to NK cells and B lymphocytes (6). In contrast, 
adult CLPs lack macrophage and LTi potential (42). In ad-
dition, commitment to the T/NK cell pathway occurs be-
fore thymic colonization in the embryo, whereas this lineage 
restriction event appears to occur after thymic colonization 
in the adult (45). Therefore, the diff  erential requirement for 
Id2 in development of NKPs reported by Ikawa et al. (29) 
and in this study is likely to be the result of the diff  erent 
origins of these progenitors. Alternatively, the role of Id2 
in thymic NK cell development may be strain dependent. 
Ikawa et al. (29) examined fetal NK cell development from 
Id2−/− mice backcrossed six generations onto the C57Bl/6 
strain, whereas our mice are backcrossed greater than eight 
generations onto the 129/SvJ strain. However, we also ob-
served no diff  erence in the number of thymic NK cells be-
tween heterozygous control and Id2−/− mice on a mixed 
129/SvJ × FVB/NJ background. Nonetheless, the interest-
ing possibility that strain diff  erences exist requires further 
investigation and may indicate diff  erential regulation of Id 
or E proteins in diff  erent strains of mice, which has not yet 
been reported.
The thymic NK cells identifi  ed by Vosshenrich et al. (14) 
are better cytokine producers, particularly of TNFα and 
IFNγ, than splenic mNK cells in response to stimulation 
with IL-2 plus IL-12. Therefore, given the thymic pheno-
type of Id2−/− splenic mNK cells, it is notable that these cells 
produced less IFNγ after cytokine stimulation than heterozy-
gous control splenic mNK cells. This observation suggests 
that Id2 may have a role in thymus-derived mNK cells that 
allows for optimal IFNγ production. This function for Id2 in 
mNK cells may also involve suppression of E protein activity, 
as splenic mNK cells in Id2−/−E2A−/− phenotypically re-
semble Id2−/− splenic mNK cells (i.e., they have the thymic 
phenotype), but they have a greater capacity for IFNγ pro-
duction. Collectively, these observations raise the possibility 
that both E and Id proteins play a role in controlling the ef-
fector functions of mNK cells. Additional studies will be re-
quired to determine the role of these proteins in mNK cells 
and how their expression is regulated.
In the absence of Id2, essentially no CD122+DX5hi mNK 
cells are found in the BM. Notably, this is the stage of NK 
cell development where Id3 mRNA is substantially reduced, 
leaving Id2 as the major Id protein in NK cells. That Id2 is 
functioning through suppression of E proteins is evident from 
our observation that deletion of E2A from Id2−/− mice re-
stores mNK cells in the BM. However, Id2−/−E2A−/− mNK 
cells show several diff  erences from heterozygous control BM 
mNK cells. Id2−/−E2A−/− BM mNK cells appear to be fully 
mature in that they express the leukosialin CD43, a marker 
of functional mNK cells (16). However, they fail to express 
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fully mature NK cells, and they produce less IFNγ than het-
erozygous control mNK cells. Id2−/−E2A−/− mNK cells are 
also present at reduced levels in peripheral blood, leading us 
to suggest that they may fail to emigrate from the BM. There-
fore, appropriate regulation of E protein activity may be criti-
cal for mNK cells to exit the BM and accumulate in peripheral 
tissues, such as the spleen. Notably, HEB and E2-2 mRNA 
levels are equivalent between BM mNK cells from Id2−/−
E2A−/− and heterozygous littermate mice, and splenic (IL7Rα−) 
mNK cells have higher levels of E2-2 and HEB than BM 
mNK cells (unpublished data). These fi  ndings raise the possi-
bility that loss of E2A may not reduce E protein activity 
  suffi   ciently in mNK cells to allow these cells to acquire com-
petence to exit the BM. At the present time, very little is 
known about the mechanisms controlling mNK cell emigra-
tion from the BM, and the E protein target genes that regu-
late this transition remain to be identifi  ed.
We have shown that loss of E2A allows progression to the 
mNK cell stage in Id2−/− BM. This fi  nding is surprising 
given that HEB and E2-2 mRNAs are expressed at higher 
levels than E2A mRNA in these cells. There are two possible 
interpretations of this fi  nding: (a) that E2A specifi  cally is in-
hibited by Id2 and (b) that loss of E2A decreases E protein 
activity suffi   ciently to allow further NK cell development, 
even though HEB and E2-2 are still present. We favor the 
second possibility because Id2 has been shown to interact ef-
fi  ciently with all E proteins in vitro (46). However, although 
E2A mRNA is expressed at lower levels than HEB and E2-2 
in NKPs, it is feasible that E2A represents the major func-
tional E protein in NK cells. E47 may have a higher affi   nity 
for the consensus E box sequence than the other E proteins, 
and posttranscriptional or posttranslational modifi  cations of E 
proteins may aff  ect their protein levels and/or activity (47, 48). 
Therefore, E2A may be the major antagonist of NK cell dif-
ferentiation in the absence of Id2.
Another interesting implication of our data is that Id pro-
teins may need only to modulate E protein activity rather 
than sequester it completely to allow for mNK cell develop-
ment, as HEB and E2-2 are expressed in BM mNK cells from 
Id2−/−E2A−/− mice. This fi   nding is intriguing given the 
range of E protein thresholds previously reported for E pro-
tein target genes. For example, in B lymphocyte progenitors, 
EBF requires a high level of E protein activity for its initial 
induction, and high levels of E protein activity are required 
for expression of N-myc as compared with c-myc (37, 49). 
Moreover, high levels of E protein activity can inhibit prolif-
eration of lymphocytes, but a reduction of E protein activity 
also leads to decreased proliferation (37, 50). These observa-
tions suggest that E proteins activate distinct target genes de-
pending on their level of expression. Therefore, our fi  ndings 
raise the possibility that low levels of E protein activity func-
tion in the regulation of gene expression in NK lineage cells 
and that Id proteins function to prevent excess E protein ac-
tivity. Further investigation of a positive role for E proteins in 
NK cell function will require the ability to knock out multi-
ple E proteins specifi  cally in NK lineage cells.
A variety of transcription factors have been identifi  ed as 
essential for proper NK cell development, including T-bet, 
Ets1, PU.1, GATA-3, IRF-1, and IRF-2 (51). Of these tran-
scription factors, T-bet, GATA-3, and IRF-2 all display de-
fects in NK cell development that occur at the fi  nal stages of 
maturation in either the BM or spleen, and the NK cells 
found in these mutant mice all exhibit functional defects. In 
contrast, the defect in NK cell development in Id2−/− mice 
occurs earlier than in T-bet−/−, GATA-3−/−, and IRF-2−/− 
mice, placing Id2 upstream of these factors. Id2−/− mice re-
semble mice lacking IL-15 in that IL-15−/− mice show a de-
creased number of mNK cells in the spleen that express NK 
cell receptors and appear to have normal NK function, al-
though iNK cells are also decreased in the BM of IL-15−/− 
mice (22). Additionally, unlike IL-15−/− and IL-15Rα−/− 
NK cells, the defect in Id2−/− NK cell development is NK 
cell intrinsic (references 20, 28; unpublished data). The defect 
in NK cell development defect in Id2−/− mice is unlikely to 
be due to a failure to respond to γc-dependent cytokines 
because Id2−/− NKPs proliferate normally in cytokine-
  supplemented in vitro culture (unpublished data). However, 
our data are consistent with the hypothesis that, in the ab-
sence of Id2, mNK cells either fail to develop or rapidly dis-
appear, and only those few cells that manage to bypass the 
need for Id2 can be observed and are therefore able to re-
spond normally to cytokines.
We found that loss of E2A in Id2−/− mice rescued devel-
opment of LNs and PPs, as well as the LTi cells that induce 
their formation. Although Id2−/−E2A−/− mice developed 
all LN subsets, Id2−/−E2A+/− mice developed mesenteric 
and cervical LNs, but axillary, brachial, and inguinal LNs 
were restored in only a subset of these animals. There are 
at least two possible explanations for the LN phenotype of 
Id2−/−E2A+/− mice: (a) that a subset of LTi cells is rescued 
that is able to induce only mesenteric and cervical LNs but 
fails to effi   ciently promote other LN subsets or (b) that only 
a small number of LTi cells develop in these mice and the 
signal delivered by these few LTi cells is suffi   cient only for 
early LN development. As there is currently no evidence 
to suggest a qualitative diff   erence in LTi cell subsets, we 
favor the latter explanation. Lymphoid tissues develop dur-
ing embryogenesis in a temporal order: mesenteric LN > 
cervical LN > brachial/axillary LN > inguinal LN > PP. 
Additionally, distinct requirements for the development of 
mesenteric and cervical LN subsets are known to exist, per-
haps the consequence of unique stromal cell subsets present 
at these locations (52). LNs are generated by the interaction 
of IL7Rα+ and TRANCE-R+ LTi cells, which express 
LIGHT and LTα1β2, with stromal “organizer” cells that ex-
press LTβR (42). This interaction promotes expression of 
adhesion molecules VCAM-1, ICAM-1, and MadCAM-1 
on the stromal cells, as well as production of chemokines, 
including CXCL13, CCL19, and CCL21, that recruit greater 
numbers of LTi cells to the developing LN and stimulate 
LTα1β2 and active α4β1-integrin expression on LTi cells. 
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to loss of distinct subsets of LNs. For example, CXCL13 and 
its receptor CXCR5 as well as LTβ are required for the de-
velopment of most peripheral but not mesenteric or cervical 
LNs (53, 54). The diff  erential requirements for development 
of mesenteric and cervical LNs when compared with other 
subsets may be due to redundancy in signaling pathways or 
varied signaling thresholds in the stromal organizer cells at 
these sites. Therefore, a decreased number of LTi cells may 
be suffi   cient for development of mesenteric and cervical, but 
not peripheral, LNs. Alternatively, our fi  ndings may be in-
terpreted as evidence of a temporal diff  erence in the ability of 
developing Id2−/−E2A+/− LTi cells to generate LN subsets. 
One possibility is that is that E2A protein accumulates dur-
ing the lifespan of LTi cells, eventually passing a threshold 
that results in decreased LTi cell survival and failed develop-
ment of LNs late in ontogeny. Regardless, the development 
of mesenteric and cervical LNs and, infrequently, other LN 
populations in Id2−/−E2A+/− mice is consistent with the no-
tion that a partial decrease in E2A rescues only a fraction of 
the total number of LTi cells in Id2−/− mice. In contrast, loss 
of E2A in these animals restores LTi cells suffi   ciently to allow 
for development of all LN populations, as well as PPs.
In summary, our data indicate that the major function 
of Id2 in lymphoid diff  erentiation is to control E protein 
  activity. During NK cell development, Id2 and Id3 may co-
operatively perform this role, and Id2 becomes essential only 
at the mNK cell stage, when Id3 mRNA is down-regulated. 
Future studies will need to address the requirement for mod-
ulation of E protein activity in NKPs and whether E proteins 
play a positive role in any aspect of NK cell development 
or function.
MATERIALS AND METHODS
Mice and genotyping. Mice were housed at the University of Chicago 
Animal Resource Center, and experiments were performed in accor-
dance with the guidelines of The University of Chicago Institutional Ani-
mal Care and Use Committee. E2A−/− mice were genotyped as described 
previously (35). Id2−/− mice were genotyped by PCR using the primers 
Id2-S, 5′-T  C  T  G  A  G  C  T  T  A  T  G  T  C  G  A  A  T  G  A  T  A  G  C  -3′; Id2-AS, 5′-C  G  T  G-
T  T  C  T  C  C  T  G  G  T  G  A  A  A  T  G  G  C  T  G  -3′; and neo, 5′-T  C  G  T  G  C  T  T  T  A  C  G  G-
T  A  T  C  G  C  C  G  C  T  C  -3′ (28). Mice were maintained on a 129/SvJ or FVB/NJ 
or mixed background. No obvious diff  erences were detected between these 
two sets of mice. More recent experiments have been performed on mice 
backcrossed onto 129/SvJ for eight generations, in which case, NK1.1 was 
not used as an NK cell marker.
Flow cytometry. Cells were treated with anti-FcγR antibody before stain-
ing with antibodies directly conjugated to biotin, FITC, PE, PE-cy5, PE-
cy5.5, PE-cy7, and APC, and antibodies specifi  c for the following antigens 
were used for this study (clone in parentheses): CD49b (DX5), CD122 
(TM-β1), CD94 (18d3), NK1.1 (PK136, which recognizes both NKR-P1B 
and NKR-P1C), CD11b (M1/70), Ly6G (RB6-8C5), CD3 (145-2C11), 
CD4 (RM4-5), CD8α (Ly-2), Ter119 (Ly-76), B220 (Ra3-6B2), c-kit 
(2B8), Sca-1 (E13-161.7), IL7Rα (A7R34), CD19 (1D3), NKG2D (CX5), 
NKG2A/C/E (20d5), Ly49D (4E5), Ly49G2 (4D11), Ly49C/I (5E6), and 
IFNγ (XMG1.2). Antibodies were purchased from eBioscience and BD 
Biosciences. Lineage cocktails were as follows: for BM, spleen and peripheral 
blood, CD3, CD4, CD8, CD19, Ter119, and Ly6G; and for thymus, CD3, 
CD4, CD8, CD19, Ter119, Ly6G, TCRβ, and CD25.
IFN𝗄 production assay. BM and spleen cells were depleted of Lin+ cells 
by magnetic sorting (Miltenyi Biotec). Cells were cultured in Opti-MEM 
supplemented with 10% FBS; penicillin, streptomycin, and glutamine solu-
tion (all from Invitrogen); 2 ng/ml IL-12 (R&D Systems); and 1,000 IU/ml 
IL-2 (National Institutes of Health). After 8 h, Golgi Plug/Brefeldin A (BD 
Biosciences) was added, and the cells were left for an additional 4 h. Cells 
were then stained for CD3 and DX5 surface antigens and placed in Cytofi  x/
Cytoperm solution (BD Biosciences) to prepare for intracellular staining us-
ing IFNγ-PE or an IgG-PE control.
Limiting dilution assay. Lin−CD122+DX5− NK progenitors from Id2+/+ 
and Id2−/− mice were sorted directly into cultures containing OPTI-MEM 
supplemented with 10% FBS, penicillin, streptomycin, and glutamine solu-
tion plus a 1:250 dilution of c-kit ligand (from MGF-CHO cells), 50 ng/ml 
Flt3L, and 1,000 IU IL-2. The cells were sorted at a concentration of 30, 10, 
and 3 cells (48 wells/cell concentration) and cultured for 10 d before analysis 
by microscopy and fl  ow cytometry analysis for Lin−CD122+CD94+ cells. 
The frequency of responding NK progenitors was determined by linear re-
gression as the number of input cells resulting in 37% nonresponding wells.
QPCR analysis. QPCR was performed as previously described (37). In brief, 
total RNA was isolated using Trizol and reverse transcribed using Superscript 
III (Invitrogen). PCR reactions were set up with fi  rst-strand cDNA, gene-
specifi  c primers, passive reference dye, and SYBR Green QPCR Master Mix 
(Bio-Rad Laboratories) according to the manufacturer’s instructions. Real-
time PCR was performed in triplicate, and fl  uorometric data were collected 
at the annealing step of each cycle. A dissociation curve was performed at 
the end of 40 cycles to confi  rm specifi  city of amplifi  cation. The primers used 
for real-time PCR analysis were designed to avoid amplifi  cation of genomic 
DNA. The primers used in this study include Id2-R, 5′-C  A  C  A  G  A  G  T  A  C  T-
T  T  G  C  T  A  T  C  A  T  T  C  G  -3′; Id2-L, 5′-C  C  T  G  A  A  C  A  C  G  G  A  C  A  T  C  A  G  C  -3′; 
E47L, 5′-G  C  C  G  A  A  G  A  G  G  A  C  A  A  G  A  A  G  G  -3′; HPRT-66F, 5′-A  C  C  T  C-
T  C  G  A  A  G  T  G  T  T  G  G  A  T  A  -3′; HPRT-66R, 5′-C  A  A  C  A  A  C  A  A  A  C  T  T  G  T-
C  T  G  G  A  -3′; Id3for, 5′-C  A  C  T  T  A  C  C  C  T  G  A  A  C  T  C  A  A  C  G  C  C  -3′; Id3rev, 
5′-C  C  C  A  T  T  C  T  C  G  G  A  A  A  A  G  C  C  A  G  -3′; Id1for, 5′-T  T  C  A  G  C  C  T  C  C  A  G-
A  G  A  C  T  T  T  G  G  G  -3′; Id1rev, 5′-C  C  G  A  G  A  A  G  C  A  C  G  A  A  A  T  G  T  G  A  C  C  -3′; 
HEBfor, 5′-C  G  A  T  T  A  G  G  A  A  C  C  C  A  C  G  A  A  G  G  -3′; HEBrev, 5′-G  G  A  A  A  A-
T  G  A  G  C  C  T  C  T  C  T  C  T  G  A  T  G  -3′; E2-2-98F, 5′-T  T  G  A  A  C  C  C  A  C  C  C  C  A  A-
G  A  C  C  C  -3′; E2-2-98R, 5′-C  G  C  C  C  T  C  G  T  C  A  T  C  G  G  A  T  T  T  G  -3′; Ets1for, 
5′-C  T  G  A  C  C  T  C  A  A  C  A  A  G  G  A  C  A  A  G  C  C  -3′; Ets1rev, 5′-T  T  C  C  A  G  A  A  G  A-
A  A  C  T  G  C  C  A  C  A  G  C  -3′; CCR1-F, 5′-C  A  T  C  A  T  C  A  T  A  C  A  G  G  A  A  G  C  C  -
A  A  G  -3′; CCR1-R, 5′-G  A  G  G  A  A  C  T  G  G  T  C  A  G  G  A  A T A  A T A  G  C  -3′; CCR5-F, 
5′-T  A  G  C  C  A  G  A  G  G  A  G  G  T  G  A  G  A  C  A  T  C  C  G  -3′; CCR5-R, 5′-G  C  A  G  G  G  T-
G  C  T  G  A  C  A  T  A  C  C  A  T  A  A  T  C  -3′; CX3CR1-F, 5′-T  C  C  C  T  T  C  C  C  A  T  C  T  G  C-
T  C  A  G  G  A  C  -3′; CX3CR1-R, 5′-A  C  A  A  T  G  T  C  G  C  C  C  A  A  A  T  A  A  C  A  G  G  -3′.
Detection of LNs and PPs. LNs were visualized 1 wk after intraperitoneal 
injection of 100 μl of a 1 mg/ml solution of Chicago sky blue (Sigma-
  Aldrich). PPs were visualized after incubation of the small intestines in a 7% 
acetic acid solution on ice for 5–10 min.
Immunofl  uorescence histology. Embryos were removed from pregnant 
females at 15.5 d postcoitum and prepared for staining as described previ-
ously (28). In brief, embryos were fi  xed overnight at 4°C in 4% paraformal-
dehyde, washed, soaked in 30% sucrose in PBS for 1 d, and frozen in OCT 
(Sakura). Sections were cut at 8 μm, adsorbed onto Superfrost-Plus slides 
(Menzer Gläser), and stained in PBS supplemented with 1% bovine serum 
and 0.1% Triton X-100. After 1 h of blocking with 10% bovine serum, sec-
tions were incubated overnight at 4°C with directly conjugated monoclonal 
antibodies, washed, and mounted with Fluoromount G (Southern Biotech-
nology Associates, Inc.). Images were taken on a microscope (AxioImager M1; 
Carl Zeiss MicroImaging, Inc.).
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